comparemela.com

Latest Breaking News On - Vistagen therapeutics - Page 13 : comparemela.com

InvestorNewsBreaks — Vistagen Therapeutics Inc (NASDAQ: VTGN) Announces Receipt from CIPO of Notice of Allowance for Dyskinesia Treatment

InvestorNewsBreaks — Vistagen Therapeutics Inc (NASDAQ: VTGN) Announces Receipt from CIPO of Notice of Allowance for Dyskinesia Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vistagen Therapeutics, Inc (NASDAQ:VTGN) Sees Significant Increase in Short Interest

Vistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 687,500 shares, a growth of 72.2% from the May 31st total of 399,200 shares. Based on an average trading volume of 215,700 shares, the […]

Vistagen Therapeutics, Inc (NASDAQ:VTGN) Short Interest Update

Vistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 687,500 shares, an increase of 72.2% from the May 31st total of 399,200 shares. Currently, 9.5% of the company’s stock are sold short. Based […]

Earnings Scheduled For June 28, 2023 - American Outdoor Brands (NASDAQ:AOUT), Aethlon Medical (NASDAQ:AEMD)

Companies Reporting Before The Bell • General Mills (NYSE:GIS) is estimated to report quarterly earnings at $1.07 per share on revenue of $5.17 billion.

Revolutionizing Mental Health Treatment: VistaGen Therapeutics Nasal Spray Solution

Revolutionizing Mental Health Treatment: VistaGen Therapeutics Nasal Spray Solution
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.